The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)

Journal of Psychopharmacology

Volumn 27, Issue 12, 2013, Pages 1149-1159

  Twardowschy, André ^a   Castiblanco Urbina, Maria Angélica ^a,b   Uribe Mariño, Andres ^a,b   Biagioni, Audrey Francisco ^a   Salgado Rohner, Carlos José ^a   Crippa, José Alexandre De Souza ^a,c   Coimbra, Norberto Cysne ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Neurosciences and Behavior (INeC)   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

5 HT1A receptors; Cannabidiol; panic attacks; prey versus predator paradigm; serotonin

Indexed keywords

CANNABIDIOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; ANXIOLYTIC AGENT; N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-(2-PYRIDINYL)CYCLOHEXANECARBOXAMIDE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; BOIDAE; COMPARATIVE STUDY; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DEFENSIVE IMMOBILITY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EPICRATES CRASSUS; ESCAPE BEHAVIOR; EVOKED RESPONSE; FEAR; MALE; MOUSE; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; PANIC; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; WILD SPECIES; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; PANIC DISORDER; PREDATION;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BOIDAE; CANNABIDIOL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEAR; INJECTIONS, INTRAPERITONEAL; MALE; MICE; PANIC; PANIC DISORDER; PIPERAZINES; PREDATORY BEHAVIOR; PYRIDINES; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN ANTAGONISTS;

EID: 84887829916     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113493363     Document Type: Article

References (56)

1. Biagioni AF, de Freitas RL, da Silva LA, et al. Serotonergic neural links from the dorsal raphe nucleus modulate defensive behaviours organised by the dorsomedial hypothalamus and the elaboration of fear-induced antinociception via locus coeruleus pathways. Neuropharmacology. 2013 ; 67: 379-394
2. Biagioni AF, Silva JA, Coimbra NC. Panic-like defensive behavior but not fear-induced antinociception is differently organized by dorsomedial and posterior hypothalamic nuclei of Rattus norvegicus (Rodentia, Muridae). Braz J Med Biol Res. 2012 ; 45: 328-336
3. Bisogno T, Hanus L, de Petrocellis L, et al. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol. 2001 ; 134: 845-852
4. Blanchard DC, Blanchard RJ Advances in the Study of Aggression. Blanchard RJ Blanchard DC, ed. New York: Academic Press ; 1984: 2-63.
5. Blanchard DC, Blanchard RJ. Ethoexperimental approaches to the biology of emotion. Annu Rev Psychol. 1988 ; 39: 43-68
6. Blanchard DC, Griebel G, Blanchard RJ. Mouse defensive behaviors: Pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev. 2001 ; 25: 205-218
7. Blanchard DC, Griebel G, Blanchard RJ. Conditioning and residual emotionality effects of predator stimuli: Some reflections on stress and emotion. Prog Neuropsychopharmacol Biol Psychiatry. 2003 ; 27: 1177-1185
8. Blanchard RJ, Griebel G, Henrie JA, et al. Differentiation of anxiolytic and panicolytic drugs by effects on rat and mouse defense test batteries. Neurosci Biobehav Rev. 1997 ; 21: 783-789
9. Blanchard DC, Griegel G, Rodgers RJ, et al. Benzodiazepine and serotonergic modulation of antipredator and conspecific defense. Neurosci Biobehav Rev. 1998 ; 22: 597-612
10. Campos AC, Guimarães FS. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology. 2008 ; 199: 223-230
11. Carlini EA, Leite JR, Tannhauser M, et al. Letter: Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents. J Pharm Pharmacol. 1973 ; 25: 664-665
12. Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: A mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA. 2006 ; 103: 7895-7900
13. Crippa JA, Zuardi AW, Hallak JE. Therapeutical use of the cannabinoids in psychiatry. Rev Bras Psiquiatr. 2010 ; 32: 56-66
14. Darwin C The Expression of the Emotions in Man and Animals. London: John Murray ; 1872:
15. Da Silva LF, Coimbra NC, Menescal-de-Oliveira L. Rostral ventromedial medulla modulates nociception and tonic immobility behavior through connections with the A7 catecholaminergic region. Behav Brain Res. 2012 ; 233: 422-427
16. Da Silva LF, Coimbra NC, Menescal-de-Oliveira L. Rostral ventromedial medulla connections in Cavia porcellus and their relation with tonic immobility defensive behavior: A biotinylated dextran amine neurotracing study. Neurosci Lett. 2013a ; 535: 116-121
17. Da Silva LA, de Freitas RL, Eichenberger GCD, et al. Chemical neuroanatomical and psychopharmacological evidence that κ receptor-mediated endogenous opioid peptide neurotransmission in the dorsal and ventral mesencephalon modulates panic-like behaviour. Eur J Pharmacol. 2013b ; 698: 235-245
18. Davis M, Hitchcock JM, Rosen JB The Psychology of Learning and Motivation: Advances in Research and Theory. Bower GH, ed. New York: Academic Press ; 1987: 263-305.
19. De Freitas RL, Salgado-Rohner CJ, Biagioni AF, et al. NMDA and AMPA/Kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by GABAA receptor blockade in the medial hypothalamus. Cereb Cortex. 2013a ;:
20. De Freitas RL, Salgado-Rohner CJ, Hallak JEC, et al. Involvement of medial prefrontal cortex on panic-like elaborated defensive behavior and innate fear-induced antinociception elicited by GABAA receptor blockade in the medial hypothalamus: Role of the endocannabinoid CB1 receptor. Int J Neuropsychopharmacol. 2013b ; 16: 1781-1798
21. Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handb Exp Pharmacol. 2011 ; 203: 75-104
22. Eichenberger GCD, Ribeiro SJ, Osaki MY, et al. Neuroanatomical and psychopharmacological evidence for interaction between opioid and GABAergic neural pathways in the modulation of fear and defense elicited by electrical and chemical stimulation of the deep layers of the superior colliculus and dorsal periaqueductal gray matter. Neuropharmacology. 2002 ; 42: 48-59
23. Fusar-Poli P, Crippa JA, Bhattacharyya S, et al. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry. 2009 ; 66: 95-105
24. Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000 ; 157: 493-505
25. Graeff FG Handbook of Anxiety: The Neurobiology of Anxiety. Burrows GD Roth M Noyes R, ed. Amsterdam: Elsevier Science Publishers ; 1990: 307-354.
26. Graeff FG. Neuroanatomy and neurotransmitter regulation of defensive behaviors and related emotions in mammals. Braz J Med Biol Res. 1994 ; 27: 811-829
27. Gray JA, McNaughton N Précis of the Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-Hippocampal System. 2000 ) Précis of the Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-Hippocampal System, 2nd ed.New York: Oxford University Press. New York: Oxford University Press ; 2000:
28. Griebel G, Blanchard DC, Blanchard RJ. Predator-elicited flight responses in Swiss-Webster mice: An experimental model of panic attacks. Prog Neuro-Psychopharmacol Biol Psychiatry. 1996 ; 20: 185-205
29. Guimarães FS, Chiaretti TM, Graeff F, et al. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmcology (Berl). 1990 ; 100: 558-559
30. Guimarães-Costa R, Guimarães-Costa MB, Pippa-Gadioli L, et al. Innate defensive behavior and panic-like reactions evoked by rodents during aggressive encounters with Brazilian constrictor snakes in a complex labyrinth: Behavioural validation of a new model to study affective and agonistic reactions in a prey versus predator paradigm. J Neurosci Meth. 2007 ; 165: 25-37
31. Hubbard DT, Blanchard DC, Yang M, et al. Development of defensive behavior and conditioning to cat odor in the rat. Physiol Behav. 2004 ; 80: 525-530
32. LeDoux JE Mind and Brain. LeDoux JE Hirst W, ed. New York: Cambridge University Press ; 1986: 301-354.
33. Lobão-Soares B, Walz R, Prediger RDS, et al. Cellular prion protein modulates defensive attention and innate fear-induced behaviour evoked in transgenic mice submitted to an agonistic encounter with the tropical coral snake. Oxyrhopus guibei. Behav Brain Res. 2008 ; 194: 129-137
34. Lopes LT, Patrone LG, Bícego KC, et al. Periaqueductal gray matter modulates the hypercapnic ventilatory response. Pflügers Arch-Eur J Physiol. 2012 ; 464: 155-166
35. Mackowiak M, Chocyk A, Dudys D, et al. Activation of CB1 cannabinoid receptors impairs memory consolidation and hippocampal polysialylated neural cell adhesion molecule expression in contextual fear conditioning. Neuroscience. 2009 ; 158: 1708-1716
36. Malfait AM, Gallily R, Sumariwalla PF, et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA. 2000 ; 97: 9561-9566
37. Marco EM, Viveros MP. Functional role of the endocannabinoid system in emotional homeostasis. Rev Neurol. 2009 ; 48: 20-26
38. McNaughton N, Corr PJ. A two-dimensional neuropsychology of defense: Fear/anxiety and defensive distance. Neurosci Biobehav Rev. 2004 ; 28: 285-305
39. Mechoulam R, Parker LA, Gallily R. Cannabidiol: An overview of some pharmacological aspects. Chem Phys Lipids. 2002 ; 121: 35-43
40. Mishima K, Hayakawa K, Abe K, et al. Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism. Stroke. 2005 ; 36: 1077-1082
41. Mobbs D, Petrovic P, Marchant JL, et al. When fear is near: Threat imminence elicits prefrontal-periaqueductal gray shifts in humans. Science. 2007 ; 314: 1079-1083
42. Moreira FA, Grieb M, Lutz B. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: Focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab. 2009 ; 23: 133-144
43. Motta SC, Goto M, Gouveia FV, et al. Dissecting the brain's fear system reveals the hypothalamus is critical for responding in subordinate conspecific intruders. Proc Natl Acad Sci USA. 2009 ; 106: 4870-4875
44. Nogueira RL, Graeff FG. Role of 5-HT receptor subtypes in the modulation of dorsal periaqueductal gray generated aversion. Pharmacol Biochem Behav. 1995 ; 52: 1-6
45. Resstel LB, Tavares RF, Lisboa SF, et al. 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol. 2009 ; 156: 181-188
46. Roser P, Vollenweider FX, Kawohl W. Potential antipsychotic properties of central cannabinoid (CB(1)) receptor antagonists. World J Biol Psychiatry. 2008 ; 11: 208-219
47. Russo EB, Burnett A, Hall B, et al. Agonistic properties of cannabidiol at 5-HT1A receptors. Neurochem Res. 2005 ; 30: 1037-1043
48. Silva RC, Brandão ML. Acute and chronic effects of gepirone and fluoxetine in rats tested in the elevated plus-maze: An ethological analysis. Pharmacol Biochem Behav. 2000 ; 65: 209-216
49. Soares VP, Campos AC, Bortoli VC, et al. Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors. Behav Brain Res. 2010 ; 213: 225-229
50. Spiacci A, Coimbra NC, Zangrossi A. Differential involvement of dorsal raphe subnuclei in the regulation of anxiety- and panic-related defensive behaviors. Neuroscience. 2012 ; 227: 350-360
51. Thiemann G, Watt CA, Ledent C, et al. Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain. Behav Brain Res. 2009 ; 200: 60-67
52. Thomas A, Baillie GL, Phillips AM, et al. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007 ; 150: 613-623
53. Thomas BF, Gilliam AF, Burch DF, et al. Comparative receptor binding analyses of cannabinoid agonists and antagonists. J Pharmacol Exp Ther. 1998 ; 285: 285-292
54. Uribe-Mariño A, Francisco A, Castiblanco-Urbina MA, et al. Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm. Neuropsychopharmacology. 2012 ; 37: 412-421
55. Weltson A, Pippa-Gadioli L, Koji-Narazaki F, et al. Neuromorphologic evidence for c-Fos-immunoreactive neurons in forebrain, diencephalon and brainstem structures involved in the elaboration of panic and fear in golden hamster after aggressive encounter with South American coral snake. Int J Psychophysiol. 2002 ; 45: 156-157
56. Zuardi AW, Antunes Rodrigues J, Cunha JM. Effects of cannabidiol in animal models predictive of antipsychotic activity. Psychopharmacology. 1991 ; 104: 260-264